Pfizer Hospira Worldwide

Pfizer Hospira Worldwide, a key subsidiary of Pfizer, is a global leader in the delivery of injectable drugs, biosimilars, and infusion technologies. Formed through Pfizer's $17 billion acquisition of Hospira in 2015, the entity integrated a vast portfolio of generic sterile injectables and medication management systems. The company is a pioneer in the biosimilars market, offering high-quality alternatives to complex biologic medicines in therapeutic areas such as oncology and inflammation. Its operations include large-scale manufacturing facilities that produce essential hospital products used in critical care and anesthesia. Pfizer Hospira Worldwide continues to play a vital role in Pfizer's broader portfolio by expanding access to affordable, life-saving treatments globally.